Latest News and Press Releases

SYDNEY, Australia and MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced the execution of...

SYDNEY, Australia and MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, is pleased to confirm it has...

Release of first commercially available mental health technology productNotable existing support from key Australian companiesProvide organizations with cost savings by reducing mental health burden ...

Led by Board of Director Franklyn Prendergast, M.D., Ph.D. and Chief Medical Officer Archie Defillo, M.D.Key external members include Martin Chapman, M.D.; Joel Ehrenkranz, M.D.; Mark A. Frye, M.D.;...

SYDNEY, Australia and MINNEAPOLIS, April 12, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, announces the completion of...

Capitalizes on 3 years of partnership success in Corporate Health programsAppoints Peta Slocombe, founder of Australia’s Biggest Mental Health Check-In, to lead Medibio Corporate Health Strategic...

Medibio’s proprietary technology to be integrated into Striiv’s mobile app that has 1m+ subscribersStriiv has corporate partnerships with UnitedHealth, Qualcomm Life, and Pfizer SYDNEY, Australia and...

SYDNEY, Australia and MINNEAPOLIS, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) announces that Mr. Peter Carlisle has been appointed to the...

SYDNEY, Australia and MINNEAPOLIS, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the...

Study designed to determine differential diagnosis in depression patientsStudy designed to monitor patient data following pharmacological treatment SYDNEY, Australia and MINNEAPOLIS, Dec. 14, 2017 ...